Armata Pharmaceuticals (ARMP) Institutional Ownership $2.30 -0.11 (-4.56%) (As of 02:50 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Institutional Ownership Changes (13F Filings) for Armata Pharmaceuticals (NYSEAMERICAN:ARMP)CurrentInstitutional OwnershipPercentage3.57%Number ofInstitutional Buyers(last 12 months)1Number ofInstitutional Sellers(last 12 months)0 Get ARMP Insider Trade Alerts Want to know when executives and insiders are buying or selling Armata Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ARMP Institutional Buying and Selling by Quarter Ad Stansberry ResearchWall St Legend Issues No. 1 Melt-Up Stock PickInvestors poured a staggering $56 billion into U.S. stock funds in just one week — the second-largest inflow since 2008... Nearly 50% of investors now describe themselves as bullish — the highest sentiment level since 2022...Click here to watch Whitney Tilson's full market briefing and claim your free stock pick today. Armata Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/18/2024 SeaCrest Wealth Management LLC32,777$137K0.0%+80.8%0.091% 11/12/2021 Renaissance Technologies LLC106,092$384K0.0%-9.1%0.425% 11/9/2021BlackRock Inc.20,571$74K0.0%+928.0%0.082% 11/8/2021 Synovus Financial Corp48,060$174K0.0%+108.4%0.193% 8/17/2021 Bridgeway Capital Management LLC113,400$450K0.0%+134.3%0.455% 8/13/2021 Renaissance Technologies LLC116,696$463K0.0%-5.8%0.468% 8/13/2021 Vanguard Group Inc.167,378$665K0.0%+121.4%0.671% 5/21/2021 Citadel Advisors LLC21,306$102K0.0%N/A0.085% 5/18/2021 Millennium Management LLC15,401$74K0.0%N/A0.062% 5/18/2021 Loomis Sayles & Co. L P129,956$621K0.0%N/A0.521% 5/18/2021 Citadel Advisors LLC21,306$102K0.0%N/A0.085% 5/13/2021 Renaissance Technologies LLC123,816$592K0.0%+25.1%0.496% 5/13/2021 Edgewood Management LLC50,000$239K0.0%+25.0%0.200% 5/12/2021 Geode Capital Management LLC10,188$48K0.0%N/A0.041% 5/12/2021 UBS Group AG6,017$29K0.0%+73.4%0.024% 5/7/2021BlackRock Inc.40,448$194K0.0%+12.4%0.162% 2/10/2021 Renaissance Technologies LLC98,996$295K0.0%+5.7%0.529% 2/5/2021BlackRock Inc.35,982$107K0.0%-12.1%0.192% (Data available from 1/1/2016 forward) ARMP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ARMP shares? During the previous two years, the following institutional investors and hedge funds held shares of Armata Pharmaceuticals shares: SeaCrest Wealth Management LLC ($137K).Learn more on ARMP's institutional investors. What percentage of Armata Pharmaceuticals stock is owned by institutional investors? 3.57% of Armata Pharmaceuticals stock is owned by institutional investors. Learn more on ARMP's institutional investor holdings. Which institutional investors have been buying Armata Pharmaceuticals stock? The following institutional investors have purchased Armata Pharmaceuticals stock in the last 24 months: SeaCrest Wealth Management LLC ($14.65K). How much institutional buying is happening at Armata Pharmaceuticals? Institutional investors have bought a total of 14,647 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Related Companies Cryoport Institutional Ownership COMPASS Pathways Institutional Ownership YS Biopharma Institutional Ownership Amylyx Pharmaceuticals Institutional Ownership Kamada Institutional Ownership Jasper Therapeutics Institutional Ownership Design Therapeutics Institutional Ownership SNDL Institutional Ownership AC Immune Institutional Ownership Alpha Teknova Institutional Ownership This page (NYSEAMERICAN:ARMP) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | SponsoredTrump’s EPIC Stock Market RallyPutting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to ...Paradigm Press | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredA huge crack is forming in the US economyFormer Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on...Wide Moat Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Armata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Armata Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
